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Initiation of translation of hepatitis A virus (HAV)
RNA occurs by internal entry and is likely to involve the
interaction of trans-acting cellular protein factors with
cis-acting structural elements of an internal ribosomal
entry segment (IRES) within the 5*-nontranslated RNA.
To characterize interactions between African green
monkey kidney (BS-C-1) cell proteins and the predicted
stem-loop IIIa (nucleotides 155–235) located at the 5*
border of the HAV IRES, we utilized an electrophoresis
mobility shift assay (EMSA) to identify a 39-kDa RNA-
binding protein (p39). Amino-terminal amino acid se-
quencing of highly purified p39 revealed absolute iden-
tity with human glyceraldehyde 3-phosphate dehydro-
genase (GAPDH). The identity of p39 as simian GAPDH
was further confirmed by antigenic and biochemical
similarities between p39 and human GAPDH. Analysis
of the RNA binding properties of simian GAPDH re-
vealed that this cellular protein interacts with two ad-
ditional sites in the HAV 5*-nontranslated RNA, one lo-
cated between nucleotides 1–148 and the other between
nucleotides 597–746. Competitive EMSAs also demon-
strated that GAPDH and human polypyrimidine tract-
binding protein, a putative picornavirus translation ini-
tiation factor, compete with each other for binding to
stem-loop IIIa, suggesting that the relative cytoplasmic
abundance of GAPDH and polypyrimidine tract-binding
protein in individual cell-types may be an important
determinant of viral translation activity. Human
GAPDH was found to destabilize the folded structure of
the stem-loop IIIa RNA based upon observed decreases
in the circular dichroism spectra of this RNA following
binding of the protein. This RNA helix-destabilizing ac-
tivity of GAPDH could directly influence IRES-depend-
ent translation and/or replication of picornavirus RNA.
Human hepatitis A virus (HAV),1 an hepatovirus of the Pi-
cornaviridae family, is a positive-strand RNA virus with a
genome length of approximately 7,480 nucleotides (1–3). The
RNA genome is organized as a relatively long 734-nt 59-non-
translated region (59NTR), a single large open reading frame
encoding the viral polyprotein, and a short 39-nontranslated
region. Among HAV strains, the 59NTR is the most conserved
region within the genome and contains extensive secondary
and tertiary RNA structure (4). The highly ordered 59NTR
contains an internal ribosomal entry segment (IRES), located
between nt 152 and the first initiator AUG at nt 735 in the
HM175 strain, which regulates initiation of translation of the
viral polyprotein by a cap-independent mechanism (5, 6). Com-
pared with other picornaviruses, HAV IRES-directed transla-
tion is extremely inefficient, a feature that may contribute to
the generally slow and noncytolytic replication of the virus in
cell culture (5–7). In addition to its role in translation, it is
likely that the 59NTR also contains regulatory elements for
initiation of positive-strand RNA synthesis (8) and possibly
encapsidation of genomic RNA.
The cap-independent initiation of translation is an impor-
tant aspect of HAV replication, strongly influencing the growth
of the virus in cell culture and probably contributing to its
pathogenicity in primates. Attenuated, cell culture-adapted
strains of HAV have mutations from the wild-type sequence
throughout the RNA genome, but these are concentrated in the
59NTR as well as the P2 and P3 regions of the viral RNA, which
encode nonstructural proteins involved in RNA replication (1,
9). Compared with wild-type virus, these attenuated viruses
demonstrate enhanced growth in cultured cells but reduced
growth in primary chimpanzee hepatocytes.2 Although muta-
tions in the P2 region are particularly important for cell cul-
ture-adaptation, studies of chimeric viruses containing 59NTR
sequences from wild-type or cell culture-adapted HAVs indi-
cate that several mutations in the 59NTR (at nt 152 and/or
203–204 and at nt 687) enhance viral growth in African green
monkey kidney (BS-C-1) cells but not fetal rhesus monkey
kidney (FRhK-4) cells (10–12). Furthermore, recent studies
have shown that two of these mutations, a UU deletion at nt
203–204 of stem-loop IIIa of the 59NTR and a U-to-G substitu-
tion in stem-loop V, act to enhance IRES-directed translation
with a cell-type specificity consistent with their effects on viral
replication (7).
The cap-independent translation of the HAV polyprotein, as
well as that of other picornaviruses, is likely to be dependent
upon the interaction of trans-acting host cell proteins with the
cis-acting IRES located within the 59NTR. This hypothesis is
supported by several observations in addition to the cell-type
specific action of the HAV mutations described above. First,
efficient poliovirus and rhinovirus translation in rabbit reticu-
locytes lysate is dependent upon supplementation of the rabbit
reticulocytes lysate with ribosomal salt wash (RSW) fractions
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fromHeLa cells (13). Similarly, it has been suggested that HAV
IRES-directed translation in rabbit reticulocytes lysate is en-
hanced following supplementation with cytoplasmic extracts
from mouse liver (14). Finally, no picornavirus IRES has been
reported to function in a wheat germ translation system, sug-
gesting the absence of necessary trans-acting factors. Multiple
cellular proteins, mostly derived from HeLa cells, have been
shown to interact with picornavirus 59NTRs. A 52-kDa nuclear
autoantigen, La, binds with specificity to the poliovirus 59NTR
and appears to be the HeLa cell factor responsible for correct-
ing aberrant translation of poliovirus RNA in rabbit reticulo-
cyte lysates (15, 16). The 57-kDa polypyrimidine tract-binding
protein (PTB), which may have a role in nuclear pre-mRNA
splicing, also binds to several picornavirus 59NTRs, including
that of HAV (17–22). Recent studies, in which PTB was de-
pleted from translationally active HeLa and Krebs-2 cell ex-
tracts, suggest that PTB may also have a role in picornavirus
translation in these cell types (18, 23). Other identified cellular
proteins that bind to the 59NTRs of picornaviruses include the
eucaryotic translation initiation factor, eIF-2A, and the elon-
gation factor EF-1a (24, 25). Indeed, it is likely that all of the
canonical translation initiation factors, with the possible ex-
ception of eIF-4f, are required for IRES-directed initiation of
picornavirus translation, in addition to the novel putative
translation factors mentioned above.
In previous studies, we utilized a UV cross-linking/label
transfer assay to identify proteins of 30, 39, and 110 kDa (p30,
p39, and p110), which are present in RSW prepared from
HAV-permissive monkey kidney cells (BS-C-1 and FRhK-4)
and which interact specifically with various RNA structural
elements of the HAV and EMCV IRES elements (19). Here, we
describe the purification of the BS-C-1 cell p39 protein and its
identification as simian glyceraldehyde 3-phosphate dehydro-
genase (GAPDH) based on amino-terminal microsequencing
and antigenic relatedness to human GAPDH. As a tetramer of
identical 37-kDa subunits, GAPDH is an important glycolytic
enzyme that utilizes NAD1 for the oxidative phosphorylation of
glyceraldehyde 3-phosphate to 1,3-diphosphoglycerate (26, 27).
Although previous studies also have shown GAPDH to be a
nucleic acid-binding protein and to possess specific DNA repair
activity, there are no previous reports of its interaction with
viral RNAs. In this study, we characterize the interaction of
GAPDH with stem-loop IIIa and other structural elements of
the HAV 59NTR.
MATERIALS AND METHODS
Reagents—Monoclonal antibody (mAb) 40.10.09 to human uracil-
DNA glycosylase/GAPDH was kindly provided by Michael Sirover
(Temple University School of Medicine, Philadelphia, PA). Goat anti-
mouse IgG1IgA1IgM and alkaline phosphatase-conjugated anti-
mouse IgG1IgA1IgM were purchased from BRL. Anti-HAV mAb 1.193
has been described previously (28). Human erythrocyte GAPDH, ribo-
homopolymers, and NAD1 were purchased from Sigma. Recombinant
human PTB was a gift from Mariano Garcia-Blanco (Duke University,
Durham, NC). Sephacryl S-300 HR, DEAE Sephacel, and heparin-
Sepharose were purchased from Pharmacia Biotech Inc., and
[a-32P]CTP (800 Ci/mmol) was obtained from Dupont NEN.
Plasmids—All HAV plasmid constructs contained sequences of the
HM175/P16 strain of HAV (9) placed downstream of the promoter for
bacteriophage T7 RNA polymerase. The numbering of HAV nucleotides
in these constructs is based on the genome of the related wild-type virus
(29). pHAV-s3a was constructed by polymerase chain reaction amplifi-
cation of a 96-base pair fragment (HAV nt 155–235) flanked by 59- and
39-terminal EcoRI and XbaI sites from pLUC-P16-CAT (7) using the
sense primer 59-AATATGAATTCCTGCAGGTTCAGG-39 and the anti-
sense primer 59-GCAATCTAGACCCTGGAAGAAAGAAGAC-39. The re-
sulting polymerase chain reaction fragment was digested with EcoRI
and XbaI and subcloned into pGEM3Zf(2). pHAV-s5 was similarly
constructed by polymerase chain reaction amplification of a 179-base
pair fragment (HAV nt 596–746) using the sense primer 59-GTGCT-
GAATTCAAACATCATTTGGCCTT-39 and the antisense primer 59-
GCAATCTAGACCCTGGAAGAAAGAAGAC-39. pHAV-D248, which
contains nt 249–746 of the HAV genome, was constructed by digesting
pHAV-CAT1 (6) with HindIII and AvrII. The resulting DNA was made
blunt ended with Klenow fragment of E. coliDNA polymerase I, and the
large fragment was isolated and religated. To confirm the sequences of
the manipulated regions within the plasmids described above, DNAs
were sequenced on a Model 373A DNA Sequencer (Applied Biosystems)
using the Taq DyeDeoxyy Terminator Cycle Sequencing Kit (Applied
Biosystems).
RNA Transcription—For synthesis of RNA probes by run-off tran-
scription, purified plasmid DNA was digested with restriction enzymes
as follows: pHAV-CAT1, SspI (HAV nt 1–148); pHAV-s3a, XbaI (HAV nt
155–235); pHAV-D248, BamHI (HAV nt 249–532); pHAV-s5, XbaI
(HAV nt 596–746); and pGEM-3Zf(2), PvuII (269 nt of a control tran-
script representing vector sequence). Transcription reactions were per-
formed with T7 RNA polymerase (Promega) and [a-32P]CTP (800 Ci/
mmol) using Riboprobe System II reagents (Promega). Following
transcription, reaction mixtures were digested with RQ1 RNase-free
DNase (Promega) at 37 °C for 15 min. Transcripts were then phenol/
chloroform extracted and ethanol precipitated and resuspended in
buffer A (20 mM HEPES, pH 7.9, 1.5 mM MgCl2, 10% glycerol (v/v), 0.5
mM dithiothreitol) with 25 mM KCl for binding assays. For analysis by
circular dichroism (CD) spectropolarimetry, resuspended RNA repre-
senting HAV nt 155–235 was dialyzed extensively against 10 mM so-
dium phosphate, 10 mM KCl, 10% glycerol (v/v), 0.1 mM EDTA, 0.5 mM
dithiothreitol.
Electrophoresis Mobility Shift Assay—EMSA conditions were
adapted from Luo and Shuman (30) and Houser-Scott et al. (31). Bind-
ing reaction mixtures (10 ml) containing 0.2–1 pmol radiolabeled probe,
2 mg of yeast tRNA, and 0.5 unit of RNasin in buffer A with 25 mM KCl
were incubated with protein for 10 min at room temperature. In exper-
iments with purified p39 or human GAPDH (Sigma), the amount of
protein added to the binding reaction was 0.1–0.5 pmol. When unla-
beled competitor RNA or monoclonal antibody (25 ng) were included,
they were added to the reaction mixture prior to the addition of p39 or
human GAPDH. Following a 10-min incubation at room temperature,
samples were electrophoresed through a native 4% polyacrylamide gel
containing 0.25 3 TBE (22.5 mM Tris borate, 0.5 mM EDTA). Electro-
phoresis was performed at room temperature at 125 V until the brom-
phenol blue marker had migrated approximately 7.5 cm into the gel.
Labeled RNA was detected by autoradiography of the dried gel.
Preparation of BS-C-1 Cytoplasmic Extract—S100 extract was pre-
pared from BS-C-1 cells as described by Chang et al. (19). Briefly,
BS-C-1 cells (10 3 900 cm2 roller bottles) were grown to 85% confluency
and harvested mechanically. Cells were washed five times with ice-cold
phosphate-buffered saline and collected by centrifugation at 150 3 g for
10 min. The cell pellet was resuspended in 10.5 ml of hypotonic lysis
buffer (10 mM HEPES, pH 7.9, 10 mM KCl, 1.5 mM MgCl2, 0.5 mM
dithiothreitol, and 0.1 mM phenylmethylsulfonyl fluoride) and homog-
enized by 50 strokes in a Dounce homogenizer. The suspension was
centrifuged at 4,300 3 g for 10 min to remove nuclei, and the resulting
supernatant was centrifuged at 100,000 3 g for 1 h. The buffer compo-
sition of the final supernatant (S100) was then adjusted to buffer A with
10 mM KCl.
Size Exclusion Chromatography of the BS-C-1 S100 Extract—BS-C-1
S-100 fraction (0.2 ml) was applied to a Sephacryl S-300 HR column (9
3 1.5 cm2) equilibrated in buffer A with 25 mM KCl. Fractions (0.4 ml)
were collected at a flow rate of 5 ml/h, and 5-ml aliquots of fractions were
analyzed by EMSA as described above.
Purification of BS-C-1 p39—BS-C-1 S100 extract (9.5 ml) was ap-
plied to a DEAE-Sephacel column (5 3 1.5 cm2) that had been equili-
brated in buffer A with 10 mM KCl. The flow-through fraction was
collected at a flow rate of 20 ml/h, and the column was eluted with 30 ml
of buffer A containing 0.5 M KCl. The flow-through fraction from the
DEAE-Sephacel was applied to a heparin-Sepharose column (2.5 3 1
cm2) that had been equilibrated in buffer A containing 10 mM KCl. The
column was eluted with 35 ml of a linear gradient of KCl (10–400 mM)
gradient in buffer A. Fractions (1.0 ml) were collected at a flow rate of
10 ml/h. Fractions 12–15, which contained the majority of the HAV
stem-loop IIIa binding activity (see “Results”) were pooled and dialyzed
against buffer A containing 25 mM KCl.
Amino Acid Sequencing—Protein from the pooled heparin-Sepharose
chromatography fractions was acetone precipitated, electrophoresed on
a 12% SDS-polyacrylamide gel, and electrotransferred to a polyvinyli-
dene difluoride membrane in 25 mM Tris, pH 8.3, 192 mM glycine, 10%
methanol. Protein bands were visualized by Coomassie Brilliant Blue
staining, and the primary band corresponding to p39 was excised. For
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amino-terminal sequencing, p39 (56 pmol) was analyzed on a gas-phase
protein sequencer (Applied Biosystems 475A). Identification of proteins
with regions homologous to the amino-terminal peptide of p39 was
performed using the BLAST program (32).
Immunoblot Analysis—BS-C-1 p39 and human erythrocyte GAPDH
(Sigma) were electrophoresed on a 12% SDS-polyacrylamide gel and
subsequently transferred electrophoretically to a polyvinylidene diflu-
oride membrane in 25 mM Tris, pH 8.3, 192 mM glycine, 10% methanol.
Immunoreactive bands were identified following successive incubations
with anti-uracil DNA glycosylase/GAPDH mAb 40.10.09 and alkaline
phosphatase-conjugated goat anti-mouse IgG1IgA1IgM. Detection
was performed with a BCIP/NBT color development system (Promega).
UV Cross-linking of RNA-Protein Complexes—The UV cross-linking
reaction was performed essentially as described by Chang et al. (19)
with some modifications. RNA binding mixtures contained 32P-labeled
RNA probe (HAV nt 155–235, 0.1 pmol/ml), 2 mg/ml yeast tRNA, and
protein in buffer A with 25 mM KCl. Following a 10-min incubation at
room temperature, samples were transferred to ice and irradiated for 20
min with a UV light source (254 nm 5.3 W: Phillips G10T5–1/2L lamp)
at a distance of approximately 4 cm. After irradiation, RNA was di-
gested with 1 mg/ml of RNase A and 0.1 unit/ml of RNase T1 for 20 min
at 37 °C. The UV cross-linked products were separated on a 12% SDS-
polyacrylamide gel and subsequently detected by autoradiography of
the dried gel.
Immunoprecipitation of UV Cross-linked GAPDH—0.3 mg of p39 or
human GAPDH were UV cross-linked with labeled HAV RNA as de-
scribed above in a 50-ml volume. The reaction mixtures were diluted to
325 ml in NTE-40 buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM
EDTA, 0.1% Nonidet-40) and divided into three 100-ml aliquots. 250 ng
of mAb to human GAPDH (40.10.09) or control mAb to HAV (1.193) was
incubated with aliquots from both the p39 and human GAPDH UV
cross-linking reactions. After a 1-h incubation at 4 °C, goat anti-mouse
IgG1IgA1IgM, and protein G-Sepharose beads (Calbiochem) were
added to reaction mixtures with occasional mixing for 1 h at 4 °C. Beads
were pelleted by centrifugation, and supernatants were collected. Beads
were washed three times with 1 ml of NTE-40 buffer, whereas super-
natants were acetone precipitated. Samples were heated to 90 °C in
Laemmli SDS sample buffer and analyzed by 12% SDS-PAGE.
Circular Dichroism—Measurements of CD spectra were performed
with a Jasco J-600 spectropolarimeter interfaced to an IBM PC micro-
computer as described previously (33). Temperature was maintained by
placing the sample (800 ml) in a 1-cm path length cylindrical cell
surrounded by an external jacket that was connected to a NesLab
recirculating water bath. To correct for baseline signals due to the cell
and buffer, CD spectra were normalized to 0 at a wavelength of 340 nm.
RESULTS
Identification of a BS-C-1 Cytoplasmic Factor That Interacts
with Stem-loop IIIa of the HAV 59NTR—Potential interactions
between proteins present in RSW or cytoplasmic extract pre-
pared from HAV-permissive BS-C-1 cells and an RNA probe
representing stem-loop IIIa of the 59NTR of HM175/P16 virus
(Fig. 1) were examined in an EMSA. This RNA segment rep-
resents the most 59 stem-loop within the IRES of HAV, as
indicated by the fact that deletion of this stem-loop but not
upstream RNA sequence significantly reduces the efficiency of
internal initiation from bicistronic RNA transcripts (5, 8). Fur-
thermore, deletion of a UU dinucleotide at nt 206–207, located
within a bulge loop of this RNA (Fig. 1), has recently been
shown to enhance translation of the viral RNA in BS-C-1 cells
(7). For these experiments, synthetic stem-loop IIIa RNA was
uniformly labeled with [32P]CTP and incubated with either the
RSW fraction or the cytoplasmic extract in the presence of
yeast tRNA (200 mg/ml) as a nonspecific competitor. Electro-
phoresis of the reaction mixtures on a 4% nondenaturing poly-
acrylamide gel revealed retarded RNA-protein complexes with
similar mass, suggesting that the RNA binding factor(s) pres-
ent in these two cell fractions may be identical (Fig. 2, lane B,
and data not shown). Binding of this factor(s) was inhibited in
the presence of 0.1% SDS, suggesting that the factor is a
protein and not nucleic acid (data not shown).
To determine the approximate molecular mass(es) of the
protein(s) that binds to the stem-loop IIIa RNA, the BS-C-1
cytoplasmic extract was fractionated on a Sephacryl S-300 HR
gel filtration column and fractions were assayed by EMSA.
Under these conditions, the binding factor producing the re-
FIG. 1. Proposed secondary structure of stem-loop IIIa within
the 5*NTR of HM175/P16 virus is supported by analysis of co-
variant substitutions in different HAV strains and by probing
the structure with single and double-strand-specific nucleases
(4, 37). Nucleotide positions are based upon the wild-type virus num-
bering (28). The arrow denotes the position of two U residues (nomi-
nally, nt 203–204) that are deleted from the wild-type sequence and
that reduce the size of a bulge loop. The bases shown represent the HAV
sequence present in the stem-loop IIIa RNA probe (nt 155–235).
FIG. 2. EMSA of BS-C-1 S100 preparation following fraction-
ation by Sephacryl S-300HR chromatography. Protein fractions
were incubated with the uniformly labeled HAV stem-loop IIIa probe
(Fig. 1) and electrophoresed on a 4% nondenaturing gel as described
under “Materials and Methods.” Molecular standards peaked at the
following fractions: blue dextran, 8; aldolase (158 kDa), 11; bovine
serum albumin (66.2 kDa), 15; and ovalbumin (42.7 kDa), 17. Lane A,
stem-loop IIIa probe; lane B, probe plus S100 fraction; lanes C–K, probe
plus S-300 HR column fractions.
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tarded RNA-protein complex in the EMSA eluted as a high
molecular weight species with an approximate mass of 150 kDa
(Fig. 2, lanes D and E). Similar results were found upon frac-
tionation of the RSW fraction on the Sephacryl S-300 HR col-
umn (data not shown). Previous results indicate that BS-C-1
proteins of 30 and 39 kDa are the major proteins present in
S100 or RSW fractions that UV cross-link to a similar HAV
59NTR probe (19). These data thus suggested that either one or
the other of these proteins exists as a high molecular weight
complex in BS-C-1 cells. Alternatively, these data could be
interpreted as showing a unique HAV RNA-binding protein
that was not identified by the earlier UV cross-linking/label
transfer assay employed by Chang et al. (19).
Purification and Amino-terminal Sequencing of the Cytoplas-
mic Factor That Binds to Stem-loop IIIa RNA—The ability to
detect stem-loop IIIa RNA binding activity by EMSA following
gel filtration chromatography suggested that EMSA could be
utilized to monitor RNA binding activity following other chro-
matographic separation techniques. Thus, in an effort to purify
the relevant RNA-binding factor, BS-C-1 cell cytoplasmic ex-
tract was applied to a DEAE-Sephacel column, and RNA bind-
ing activity was recovered in the flow-through fraction (Fig. 3A,
lane C). This was followed by heparin-Sepharose chromatogra-
phy, which resulted in a peak of RNA binding activity eluting
at approximately 150 mM KCl (Fig. 3A, lanes H and I). Analysis
of the pooled fractions (12–15) containing this peak binding
activity by 12% SDS-PAGE followed by silver staining revealed
a major protein band of 39 kDa that was approximately 85%
pure (Fig. 3B). The UV cross-linking/label transfer assay using
the pooled fractions also revealed a 39-kDa protein as the
primary species to which 32P label was transferred from the
stem-loop IIIa RNA (Fig. 3C). Together, these data provided
strong evidence that the 39-kDa protein was responsible for
producing the RNA-protein complex in the fractions analyzed
by EMSA. These data also suggest that p39 exists as part of a
high molecular weight complex. It is likely that this 39-kDa
protein is identical to p39, which we have previously shown to
bind specifically to multiple sites within the HAV 59NTR using
the UV cross-linking/label transfer assay (19).
Following SDS-PAGE, the purified p39 protein was electro-
blotted onto a polyvinylidene membrane and subjected to ami-
no-terminal amino acid sequencing with 27 rounds of Edman
degradation. 25 of the first 27 amino acids of the 39-kDa pro-
tein were identical to the analogous residues of human GAPDH
and a minor human uracil DNA glycosylase species, which
recently has been shown to be the monomer subunit of GAPDH
(34) (Table I). The nature of the remaining two residues of p39
(both Arg in GAPDH) could not be determined following Ed-
man degradation. Human GAPDH is a tetrameric protein com-
prised of four 37-kDa monomers that plays an important role in
glycolysis but that is multifunctional and interacts specifically
with both tRNA and AU-rich eucaryotic mRNAs (35, 36).
Confirmation That the 39-kDa BS-C-1 RNA Binding Factor
Is Simian GAPDH—To confirm that the RNA binding factor
p39 is in fact GAPDH, a series of experiments were carried out
comparing p39 and human erythrocyte GAPDH (Sigma). First,
purified p39 and human GAPDH were probed in immunoblots
with the anti-human uracil DNA glycosylase/GAPDH mAb
40.10.09 (Fig. 4A). As expected, the 40.10.09 mAb detected a
single band of 37 kDa representing human GAPDH (Fig. 4A,
lane B). In addition, the 40.10.09 mAb also recognized the
BS-C-1 p39 protein, which migrated with a slightly higher
apparent molecular mass than human GAPDH (Fig. 4A, lane
B). Comparison of these two proteins by SDS-PAGE and silver
staining also revealed this slight difference in apparent molec-
ular mass (data not shown).
As with BS-C-1 p39, human GAPDH was found to be labeled
after UV cross-linking with 32P-labeled stem-loop IIIa RNA
followed by extensive RNase digestion (Fig. 4B, lanes A and F).
As additional evidence that p39 was in fact GAPDH, the re-
sulting radiolabeled RNA-protein complexes could be immuno-
precipitated with the anti-GAPDH 40.10.09 mAb but not with
a control mAb directed against HAV capsid, 1.191 (Fig. 4B).
Finally, purified GAPDH formed a primary complex with stem-
loop IIIa RNA in EMSA, with a shift in mobility similar to the
p39-RNA complex (Fig. 4C, lanes B and E). When the ratio of
protein to stem-loop IIIa RNA was increased, a second minor
RNA-protein complex with more retarded mobility formed with
both p39 and GAPDH (data not shown). A very small amount of
this secondary complex is apparent in Fig. 4C (lanes B and G).
The addition of the 40.10.09 anti-GAPDH mAb further re-
TABLE I
Amino-terminal amino acid sequence of BS-C-1 p39 determined by
amino-terminal sequencing and alignment with the sequence of an
homologous peptide from human GAPDH
Protein Amino acid sequencea Position
BS-C-1 p39 GVKVGVNGFGXIGGXLVTRAAFNSG
u u u u u u u u u u u u u u u u u u u u u u u
Human GAPDH GVKVGVNGFGRIGGRLVTRAAFNSG 2–28
a X denotes amino acid residues that could not be clearly identified in
the Edman degradation.
FIG. 3. Isolation of a 39-kDa protein
that binds to HAV stem-loop IIIa
RNA. A, BS-C-1 S100 fraction was ap-
plied to a DEAE-cellulose anion exchange
column and the flow-through fraction was
further fractionated by heparin-Sepha-
rose chromatography as described under
“Materials and Methods.” Fractions were
assayed by EMSA for their stem-loop IIIa
binding activity. Lane A, labeled stem-
loop IIIa RNA probe. Lanes B-O contain
RNA incubated with BS-C-1 S100 fraction
(lane B), DEAE flow-through (FT) frac-
tion (lane C); heparin-Sepharose flow-
through fraction (lane D); and heparin-
Sepharose elution fractions 3–33 (lanes
E–O). B, heparin-Sepharose fractions
12–15 were pooled and further analyzed
by 12% SDS-PAGE followed by silver
staining. C, transfer of label from stem-
loop IIIa RNA to a 39-kDa protein in the
pooled heparin-Sepharose fractions fol-
lowing UV cross-linking and extensive
RNase digestion.
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tarded (supershifted) the migration of the major RNA-protein
complex in EMSA reactions containing radiolabeled stem-loop
IIIa RNA complexed to either BS-C-1 p39 or human GAPDH
(Fig. 4C, lanes C and F). No such supershift was apparent with
the control 1.191 mAb (Fig. 4C, lanes D and G), whereas addi-
tion of the 40.10.09 mAb to the RNA probe in the absence of
either p39 or GAPDH also resulted in no shift (Fig. 4C, lane H).
The RNA binding properties of BS-C-1 p39 and human
GAPDH were compared with each other to further confirm the
identity of p39 as simian GAPDH. Nagy and Rigby (36) previ-
ously demonstrated that GAPDH binds RNA in its NAD1 co-
enzyme binding site (otherwise known as the “Rossmann fold”).
In competitive binding experiments with p39 or human
GAPDH, NAD1 inhibited binding of both proteins to stem-loop
IIIa RNA at nearly identical concentrations (Fig. 5). In addi-
tion, various unlabeled ribohomopolymers competed with 32P-
labeled stem-loop IIIa RNA for binding with p39 or human
GAPDH with approximately equal efficiencies (Fig. 6). As dem-
onstrated previously in competitive binding experiments with
the 39NTR of the interferon-g 39 mRNA (36), poly(U) was the
strongest competitor of RNA binding to GAPDH as well as the
BS-C-1 p39 protein (Fig. 6, lanes D and K). A lesser degree of
binding competition was observed at the highest concentration
of poly(A), whereas poly(C) had no apparent effect on stem-loop
IIIa binding to GAPDH or p39.
Specificity of Simian GAPDH Binding to the HAV
59NTR—To localize the binding sites of simian GAPDH (BS-
C-1 p39) within the HAV 59NTR and confirm previous obser-
vations of the specific binding of p39 to HAV RNA, we deter-
mined the ability of various unlabeled RNA probes
representing different structural elements of the HAV 59NTR
to compete for binding to purified p39 in the UV cross-linking/
label transfer assay. The unlabeled competitor probes are
shown in Fig. 7A and included RNA transcripts corresponding
to nt 1–148 (representing stem-loops I-IIb in addition to the
most 59 pyrimidine-rich tract, pY1), nt 155–235 (stem-loop
IIIa), nt 249–632 (stem-loops IIIb-IV), and nt 596–744 (stem-
loop V to the initiator AUG codon) (4, 37). In addition, a 269-nt
transcript (GEM-t) derived from pGEM3Zf(2) was utilized as a
nonspecific competitor RNA in these experiments. In the UV
cross-linking/label transfer assay, the 1–148 and 155–235 nt
probes were the strongest competitors, followed by the 596–744
nt probe (Fig. 7B). Both the 249–632 nt HAV probe and the
control GEM-t were relatively weak competitors showing little
if any effect at molar concentrations 200-fold in excess of the
radiolabeled stem-loop IIIa RNA. These data thus support the
specific nature of the interaction between GAPDH and stem-
loop IIIa RNA but confirm earlier observations that p39
(GAPDH) binds to several sites within the 59NTR (19). Impor-
tantly, the three sites that specifically bound purified simian
GAPDH in the UV cross-linking/label transfer assay did not
differ from those that were previously found to bind the 39-kDa
protein identified in a crude BS-C-1 cell extract (19). This
provides further evidence that these proteins are identical.
Because the 249–632-nt and 596–744-nt HAV RNA probes
overlap each other by 37 nt, the low affinity GAPDH binding
activity of the latter probe is likely to be located between nt 633
and 744 or to be dependent upon the presence of an intact
stem-loop Va (4).
GAPDH and PTB Compete for Binding to HAV Stem-loop
FIG. 4. Antigenic relatedness of BS-C-1 p39 and human GAPDH. A, immunoblot of purified BS-C-1 p39 (lane A) and human GAPDH (lane
B) probed with mouse monoclonal anti-human GAPDH antibody 40.10.09. B, immunoprecipitation of UV cross-linked BS-C-1 p39 and human
GAPDH. Purified p39 (lanes A–E) or human GAPDH (lanes F–J) were UV cross-linked to 32P-labeled stem-loop IIIa RNA and extensively digested
with RNases prior to SDS-PAGE. Labeled proteins (lanes A and F) were tested for their ability to be immunoprecipitated with anti-GAPDH
monoclonal 40.10.09 (supernatant, lanes B and G; pellet lanes C and H) or control mouse monoclonal antibody to HAV capsid 1.193 (supernatant,
lanes D and I; pellet, lanes E and J). C, mobility supershift of BS-C-1 p39-RNA and human GAPDH-RNA complexes with anti-GAPDH antibody.
Lane A, labeled HAV stem-loop IIIa RNA probe. EMSA reactions contained RNA incubated with BS-C-1 p39 (lanes B–D) or human GAPDH (lanes
E–G) in the presence of no antibody (lanes B and E), anti-GAPDH monoclonal 40.10.09 (lanes C and F), or control antibody 1.193 (lanes D and G).
Lanes H and I represent probe reacted with antibody 40.10.09 (lane H) or 1.193 (lane I) in the absence of p39 or GAPDH.
FIG. 5. EMSA demonstrating competition between the coen-
zyme NAD1 and stem-loop IIIa RNA for binding to purified
BS-C-1 p39 and human GAPDH. Lane A, labeled stem-loop IIIa RNA
probe. EMSA reactions contained probe incubated with BS-C-1 p39
(lanes B–E) or human GAPDH (lanes F–I) in the absence of added
NAD1 (lanes B and F) or in the presence of 0.01 (lanes C and G), 0.1
(lanes D and H), or 1 mM NAD1 (lanes E and I).
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IIIa—Several lines of evidence suggest that GAPDH and PTB,
a putative picornavirus translation initiation factor (18, 21),
have similar RNA binding specificities. This includes the sim-
ilar binding specificity of these proteins for ribohomopolymers
(36, 38) and previous observations suggesting that BS-C-1 p39
and HeLa cell p57 (PTB) compete for similar binding sites on
the HAV 59NTR (19). To determine whether GAPDH and PTB
compete for binding to a functionally significant region of the
HAV 59NTR, we carried out UV cross-linking/label transfer
assays with uniformly labeled stem-loop IIIa RNA and reaction
mixtures containing both human GAPDH and PTB in varied
molar ratios (Fig. 8). As expected, in reactions with GAPDH or
PTB alone, the label was transferred to proteins of 37 or 57
kDa, respectively, with label transfer to PTB being more effi-
cient than to GAPDH (Fig. 8, lanes A and I). However, in
reactions with equimolar quantities of the two RNA-binding
proteins, label transfer to GAPDH was significantly reduced,
whereas label transfer to PTB was not impaired (Fig. 8, lane E).
When the molar concentration of PTB was 10-fold higher than
GAPDH, label transfer to GAPDH was not detected, whereas a
10-fold molar excess of GAPDH resulted in only a modest
reduction of label transfer to PTB. These results are consistent
with competition between GAPDH and PTB for binding to
similar or overlapping sites on the stem-loop IIIa RNA and
indicate that the binding affinity of PTB is substantially higher
than that of GAPDH.
Circular Dichroism Spectra of Stem-loop IIIa RNA Com-
plexed with Human GAPDH—Previously, both yeast GAPDH
and human GAPDH (P8 protein) were found to possess a helix
destabilizing activity that could depress the melting tempera-
ture of poly(A-U) by as much as 28 and 24 °C, respectively (39).
By definition, helix destabilizing proteins bind single-stranded
polynucleotides with higher affinity than double-stranded hel-
ical polynucleotides, with the resulting equilibrium favoring
the single-stranded conformation (40). A common experimental
property of several helix destabilizing proteins, including yeast
GAPDH and the prototype T4 bacteriophage gene 32 protein
(39, 40), is that they affect a substantial decrease in the CD
spectra of helical nucleic acids. This phenomenon has been inter-
preted as evidence for protein-induced melting of the polynucle-
otide helix accompanied by unstacking of nucleic acid bases.
To determine whether the reported helix-destabilizing activ-
ity of GAPDH extended to its interaction with stem-loop IIIa
RNA, we examined the effect of GAPDH binding on the CD
spectra of this RNA. Fig. 9A depicts the CD spectra of isolated
stem-loop IIIa RNA in the absence of protein at temperatures
FIG. 6. EMSA demonstrating competition between ribo-
homopolymers and stem-loop IIIa RNA for binding to BS-C-1
p39 and human GAPDH. Lane A, stem-loop IIIa RNA probe. EMSA
reactions contained probe incubated with BS-C-1 p39 (lanes B–H) or
human GAPDH (lanes I–O) in the presence of no competitor (lanes B
and I), 1 ng of poly(U) (lanes C and J), 10 ng of poly(U) (lanes D and K),
1 ng of poly(C) (lanes E and L), 10 ng of poly(C) (lanes F andM), 1 ng of
poly(A) (lanes G and N), or 10 ng of poly(A) (lanes H and O).
FIG. 7. Competition between sev-
eral unlabeled RNAs representing
segments of the HAV 5*NTR and la-
beled stem-loop IIIa RNA for binding
to BS-C-1 p39 (simian GAPDH). A, pre-
dicted secondary and tertiary structure
(4, 37) of the 59NTR of HM175/P16 virus
in the regions represented by unlabeled
RNA probes 1–148, 249–632, and 596–
746 used in competition experiments. In-
dividual stem-loops are labeled I, IIa, etc.,
whereas pY1 denotes the 59 pyrimidine-
rich tract. Base pair interactions in puta-
tive pseudoknots are indicated by shaded
areas. The two boxes indicate the initiator
codons (1 and 3) at the 59 end of the long
ORF. Nucleotide numbering is that of the
related wild-type virus (28). B, competi-
tive UV cross-linking/label transfer reac-
tions containing 32P-labeled stem-loop
IIIa RNA (Fig. 1) incubated with purified
BS-C-1 p39 in the presence of a 20- or
200-fold molar excess of unlabeled syn-
thetic RNAs representing various seg-
ments of the HAV 59NTR (lanes B–I) or an
unrelated 269-nt control RNA transcribed
from pGEM3Zf(2) DNA linearized by di-
gestion with PvuII (lanes J and K). No
RNA competitor was present in lane A.
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ranging from 10 to 80 °C. Inspection of these spectra reveals a
positive band centered at approximately 268 nm, with a pro-
gressive reduction in the molar ellipticity between 250 and 290
nm with increasing temperatures. Because the structure of
stem-loop IIIa RNA has previously been shown to have signif-
icant double-stranded character (4, 37), the reduction in inten-
sity of the stem-loop IIIa RNA spectra with increasing temper-
ature is likely to reflect disruption of base pair interactions that
are present in the folded conformation of this RNA. Fig. 9B
shows the CD spectra of stem-loop IIIa RNA (250 nM) at 15 °C
in the presence of three different concentrations of human
GAPDH (1, 2, and 4 mM), as well as the CD spectra of isolated
human GAPDH at concentrations of 2 and 4 mM. The minimal
ellipticity of isolated GAPDH at wavelengths greater than 250
nm (Fig. 9B) allowed a straightforward assessment of the effect
of this protein on the CD spectra of the RNA between 250 and
290 nm. The addition of even low concentrations of GAPDH
(1–2 mM) to stem-loop IIIa RNA resulted in a significant reduc-
tion in the intensity of the RNA spectra at wavelengths be-
tween 250 and 290 nm (Fig. 9B). This effect was dependent
upon the concentration of GAPDH and resembled the reduction
in ellipticity, which was observed upon thermal denaturation of
the RNA (Fig. 9A). In contrast to GAPDH, the addition of a
10-fold molar excess of albumin to stem-loop IIIa RNA had no
effect on the CD spectra of the RNA between 250 and 290 nm
(data not shown). These data thus indicate that the binding of
GAPDH to stem-loop IIIa RNA significantly destabilizes the
secondary structure of this RNA, suggesting that GAPDH
binds the single-stranded RNA with greater affinity than hel-
ical segments of this stem-loop or that it converts helical seg-
ments to unpaired strands.
Fig. 9C shows the molar ellipticity of RNA-GAPDH mixtures
at the peak wavelength (268 nm) as a function of the molar
ratio of monomeric GAPDH to stem-loop IIIa RNA (held con-
stant at 250 nM) (molar ellipticity normalized for the spectral
contribution of GAPDH). These results show that a molar ratio
of monomeric GAPDH to RNA of approximately 4:1 is required
for a half-maximal change in the RNA structural perturbation.
If GAPDH is predominantly tetrameric under the conditions of
this experiment, these results would suggest that a ratio of one
GAPDH tetramer/RNA molecule is required for half-maximal
destabilization of the RNA structure. However, although
GAPDH is predominantly a tetrameric protein, further inter-
pretation of these results is hindered by the fact that GAPDH
FIG. 8. Competition between GAPDH and PTB for binding to
labeled stem-loop IIIa RNA in a UV cross-linking/label transfer
assay. Lane A contains products of a UV cross-linking reaction with
isolated GAPDH, whereas lane I contains products of UV cross-linking
to PTB. Lanes B–H contain varying molar ratios of monomer GAPDH
and PTB as indicated at the top. The molar quantities of human
GAPDH (monomer) or human PTB in a 15-ml binding reaction are also
indicated.
FIG. 9. CD spectropolarimetry of stem-loop IIIa RNA in the
presence and absence of GAPDH. Spectra were obtained in 10 mM
NaPO4, pH 7.7, 10 mM KCl, 0.1 mM Na2EDTA, 0.5 mM dithiothreitol,
10% glycerol. A, CD spectra obtained during progressive thermal dena-
turation of stem-loop IIIa RNA (concentration, 225 nM) at 10, 30, 40, 50,
and 80 °C. The molar ellipticity values in the 250–280 nm range de-
creased as the temperature was increased. B, the effect of human
GAPDH on the CD spectra of stem-loop IIIa RNA. Spectra shown were
obtained at 15 °C with stem-loop IIIa RNA (concentration, 250 nM) and
GAPDH (molar concentrations of the 37-kDa monomer equal to 0, 1, 2,
and 4 mM). The molar ellipticity values in the 250–280 nm range
decreased significantly as the concentration of GAPDH was increased.
Spectra of GAPDH alone (2 and 4 mM concentrations) are also shown;
molar ellipticity values in the 250–300 nM range with the protein alone
are only slightly below the buffer baseline. Thus, the ellipticity observed
in this range with the mixture of RNA and GAPDH is contributed
almost exclusively from the RNA. C, the change in molar ellipticity of
stem-loop IIIa RNA at 268 nm is plotted as a function of the molar ratio
of monomeric GAPDH to RNA. Molar ellipticity values at GAPDH
concentrations of 2, 4, and 8 mM were normalized for the molar elliptic-
ity contribution of GAPDH at these concentrations.
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can exist as an equilibrium mixture of tetramers, monomers,
and possibly dimers under conditions where the concentration
of protein is relatively low, such as those described in Fig. 9C
(41–43). Although the monomeric form of GAPDH has been
reported to bind poly(dU) and to possess an associated uracil
DNA glycosylase activity (34), it is still not clear which form(s)
of GAPDH bind to RNA. Furthermore, it is also unknown
whether GAPDH binding to RNA affects the relative abun-
dance of tetramers, dimers, and monomers.
DISCUSSION
Although the precise mechanism by which picornavirus
translation is initiated remains unknown, it is likely to depend
upon the interaction of trans-acting cellular factors with cis-
acting elements of the 59NTR, which result in the binding of the
40 S ribosomal subunit at a position that is favorable for
translation to be initiated at the proper AUG initiator codon.
Studies that examined the translation of HAV RNA in rabbit
reticulocyte lysates indicated that the HAV IRES is located
between nt 151–735 of the 59NTR (5). Interestingly, the 59
border of the HAV IRES coincides with a stem-loop structure
(domain IIIa), which suggests that base pairing in this region is
important for IRES-directed translation (Figs. 1 and 7A) (4, 5,
37). Immediately 59 of this stem-loop there is an extended
single-stranded domain within which deletions do not signifi-
cantly impair translation but do result in a temperature-sen-
sitive replication phenotype due to a reduction in RNA synthe-
sis (8, 37). Within stem-loop IIIa, a deletion of two U residues
at nt 206–207, which normally contribute to a bulge-loop in this
RNA, has been shown to enhance the growth of cell culture-
adapted virus in continuously cultured African green monkey
kidney (BS-C-1) cells due to a specific enhancement of IRES-de-
pendent translation in these cells (7, 12). Thus, several independ-
ent lines of evidence indicate that stem-loop IIIa plays an impor-
tant role in the initiation of HAV translation by internal entry.
Here, we show that a protein of approximately 39 kDa (p39),
which is present in BS-C-1 cell cytoplasmic extracts and RSW
fractions and which binds with relative specificity to stem-loop
IIIa RNA, is simian GAPDH. The identification of this protein
as GAPDH was based upon several comparisons of the purified
p39 RNA-binding protein with human GAPDH, a tetrameric
protein that is composed of four identical 37-kDa subunits (26,
27). First, amino-terminal amino acid sequencing of p39 re-
vealed absolute identity between p39 and human GAPDH at
the 25 amino acid residues that were identified in the first 27
cycles of Edman degradation (Table I). In addition, as with the
BS-C-1 p39 protein, human GAPDH also was UV cross-linked
in RNA binding reactions with radiolabeled stem-loop IIIa
RNA and formed a complex with this RNA in EMSA that
migrated in similar fashion to the p39-RNA complex in a non-
denaturing acrylamide gel (Fig. 4). Furthermore, p39 and hu-
man GAPDHwere found to be antigenically related based upon
immunoblot analysis, immunoprecipitation of stem-loop IIIa
RNA-protein complexes with anti-GAPDH monoclonal anti-
body, and a mobility supershift of this complex by anti-GAPDH
antibody in EMSA (Fig. 4). Competition binding experiments
with NAD1 and the ribohomopolymers poly(U), poly(C), and
poly(A) demonstrated strong similarities between p39 and hu-
man GAPDH (Figs. 5 and 6). Finally, because GAPDH exists
primarily as a tetrameric protein (26, 27), the identification of
p39 as simian GAPDH is also consistent with our finding that
the RNA binding activity of p39 elutes from a size exclusion
column with an apparent molecular mass of approximately 150
kDa (Fig. 2).
Previous studies have shown that GAPDH is an abundant,
multifunctional enzyme that is primarily cytoplasmic but also
present in the nucleus (35). In addition to its role in glycolysis,
several unrelated activities have been attributed to GAPDH
including DNA repair (34), protein phosphorylation (44), and
interaction with RNA (35, 36), DNA (34, 45), microtubules (46),
and red cell membranes (47). Similar to our finding that
GAPDH binds to several regions within the HAV 59NTR,
GAPDH has been shown recently to bind to certain tRNAs and
eucaryotic mRNAs (35, 36). It has been reported that GAPDH
binds yeast tRNASer with an apparent dissociation constant
(Kd) of approximately 1.8 3 10
28 M and other tRNAs with high
affinity and has been suggested to participate in the export of
tRNAs from the nucleus (35). Although we have not measured
the Kd of GAPDH for different segments of the HAV 59NTR in
this study, it is not unreasonable to assume that it possesses an
affinity for stem-loop IIIa RNA that is at least comparable with
its affinity for yeast tRNAs, because these tRNAs were present
at high concentration (200 mg/ml) as “nonspecific” competitors
in our binding assays. Nagy and Rigby (36) have shown that
GAPDH interacts specifically with AU-rich elements of mRNAs
and have proposed that this interaction plays a role in regu-
lating AU-rich elements-dependent mRNA translation. The
AU-rich elements RNA binding region of GAPDH was localized
to the NAD1 binding domain or dinucleotide-binding (Ross-
mann) fold of the enzyme, consistent with our finding that
binding of p39 or GAPDH to stem-loop IIIa RNA is inhibited by
NAD1 (Fig. 5).
Competitive binding experiments confirmed that GAPDH
(p39) binds to multiple sites within the HAV 59NTR. GAPDH
was found to bind RNA probes representing nt 1–148, 155–235,
and 596–746 but with greatest affinity to the nt 1–148 (which
contains the pY1 pyrimidine-rich tract) and nt 155–235 (stem-
loop IIIa) RNAs (Fig. 7). In previous UV cross-linking/label
transfer studies, the 39-kDa protein present in BS-C-1 cell
extracts was found to have similar binding specificities, which
strongly suggests that our purified p39 is identical to this
previously identified protein (19). GAPDH is thus similar to
PTB in its interaction with the 59NTR, because PTB also binds
to multiple sites within the 59NTRs of HAV and other picorna-
viruses (18–22). We previously found that p39 binds specifi-
cally to RNA probes representing the IRES of encephalomyo-
carditis virus, a picornavirus, as well as the 59NTR of hepatitis
C virus, a member of the Flaviviridae that also translates its
polyprotein by an IRES-directed mechanism (19, 48, 49). In
addition, in preliminary studies we have found that both sim-
ian GAPDH and human GAPDH interact with the poliovirus 59
cloverleaf in a UV cross-linking/label transfer assay.3 These
data raise the possibility that GAPDH may be identical to a
36-kDa cellular protein of HeLa cells that has been implicated
in promoting the binding of the poliovirus 3CDpro protein to the
59 end of the viral plus-strand RNA, in a step that is critically
important for replication of the viral RNA (50). The affinity of
GAPDH for the 59NTRs of several different positive-strand RNA
viruses suggests that it might contribute functionally to the rep-
lication of these viruses by one or more specific mechanisms.
Although we have not determined whether GAPDH plays a
role in the replication of HAV, the ability of GAPDH to decrease
the melting temperature of poly(A-U) (39) suggested that it
might function to destabilize RNA structural elements that
regulate translation initiation or RNA replication. In support of
this hypothesis, we found that GAPDH specifically reduces the
intensity of the circular dichroism spectra of stem-loop IIIa
RNA (Fig. 9B), indicating that GAPDH binding favors the
single-stranded form of this RNA over its predicted stem-loop
conformation (Fig. 1). Because the functional activities of
IRESs are strongly dependent upon their secondary RNA
3 D. E. Schultz, and S. M. Lemon, unpublished results.
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structure (51), it is tempting to speculate that the destabiliza-
tion of stem-loop IIIa structure by GAPDH would adversely
influence internal initiation of translation directed by the HAV
IRES. However, different mechanisms can be envisioned
whereby GAPDH could have a positive or negative impact on
translation, depending upon whether the initial contact site of
the 40 S ribosome subunit or translation initiation factors that
might bind to the IRES in advance of the ribosome is a highly
structured or single-stranded RNA conformation. Either way,
it is important to note that the cytoplasmic abundance of
GAPDH distinguishes it from the putative picornaviral trans-
lation initiation factors, La and PTB, which are predominantly
nuclear proteins.
Although PTB has been suggested to function as a trans-
acting factor in initiation of picornavirus translation (18, 23), it
is interesting that BS-C-1 cells that are permissive for both
HAV and poliovirus have extremely low levels of this protein
compared with the levels found in HeLa cells (18, 19). Unlike
PTB, GAPDH is expressed at relatively high levels in all living
cells because of its important role in carbohydrate metabolism.
We demonstrated that PTB and GAPDH compete with each
other for binding to stem-loop IIIa of the HAV 59NTR (Fig. 8).
This suggests the interesting possibility that the functional
role of PTB in IRES-directed translation may be to compete
with and prevent the binding of GAPDH to the IRES with its
attendant RNA helix destabilizing activity. Alternatively, bind-
ing of GAPDH to the 59NTR could indirectly influence internal
initiation of translation by limiting the interaction of the pu-
tative trans-acting factor PTB with structural elements of the
IRES. In either case, the functional impact of interactions of
GAPDH and PTB with picornavirus RNAs is likely to be de-
pendent upon the relative abundance of these proteins within
the cytoplasm of specific cell types. Thus, competition between
PTB and GAPDH for identical or at least overlapping binding
sites on viral RNA may contribute substantially to the cell
type-specific differences in RNA-binding proteins that were
identified previously in BS-C-1 and HeLa cell extracts (19).
It is interesting that the two mutations in the 59NTR of the
cell culture-adapted HM175/P16 virus that enhance IRES-di-
rected translation in BS-C-1 cells (7), a UU deletion at position
203–204 and a U-to-G substitution at position 687, both remove
uracil bases from potential GAPDH binding sites. Because
GAPDH binding sequences are characteristically U-rich (Fig.
6) (36), such mutations would be predicted to reduce the affin-
ity of the RNA for GAPDH. This line of reasoning is consistent
with the hypothesis that binding of GAPDH to the HAV 59NTR
may be detrimental to IRES-directed translation and that
these mutations might decrease this interaction in the low PTB
environment of BS-C-1 cells and thereby enhance cap-independ-
ent viral translation. However, it should be noted that these
mutations do not enhance viral translation in HAV-permissive
FRhK-4 cells, which also have a very low abundance of PTB
and have proteins of 30 and 39 kDa (GAPDH), which bind
specifically to elements of the HAV IRES (7, 19).
Independent of translation, the interaction of GAPDH with
the 59 end of HAV RNA could also contribute to replication of
the viral RNA. Although speculative, it is possible that the
helix destabilizing activity of GAPDH could promote the disso-
ciation of positive and negative strands of the replicative form
RNA, thereby facilitating the separation of these strands,
which is required for initiation of further rounds of positive-
strand RNA synthesis (50). Alternatively, destabilization of
secondary structure within the 59NTR could facilitate the pas-
sage of the RNA replicase during synthesis of negative-strand
RNA. Further experiments will be required to test these
possibilities.
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